Alpha Vision to Unveil Advanced AI Surveillance Suite for Retail at ISC West 2025

"Our AI-driven platform is a game-changer for physical security. By combining AI Inspector, Magic Search, and Virtual Guard, we're empowering businesses to prevent incidents before they happen, find critical video evidence in seconds, and respond to threats proactively. These capabilities translate to real-world ROI – greater safety, lower losses, and improved efficiency across retail, property management, and more", said Yi Jin, Ph.D., Head of Marketing at Alpha Vision.

Alpha Vision will showcase its AI Inspector, Magic Search, and Virtual Guard at ISC West 2025 (booth #5076), demonstrating an integrated AI suite that boosts security and delivers measurable ROI for retailers and beyond.

Sunnyvale, CA - March 31, 2025 - Alpha Vision, an AI security technology company, announced it will unveil its complete AI-powered surveillance solution suite at ISC West 2025, the security industry’s premier conference. At booth #5076, the company will debut AI Inspector, Magic Search, and Virtual Guard – a trio of advanced tools designed to work together to enhance safety, streamline monitoring, and reduce costs across retail, commercial real estate, and other industries.

In an era of rising retail theft and strained security resources, businesses are seeking smarter surveillance solutions. Alpha Vision’s announcement comes at a crucial time as organizations look for technology to improve safety and efficiency. AI Inspector provides autonomous 360-degree camera patrols with real-time AI detection, Magic Search enables instant retrieval of video footage via natural language queries, and Virtual Guard offers 24/7 remote monitoring with customizable voice alerts to deter intruders on the spot.

“Our AI-driven platform is a game-changer for physical security,” said Yi Jin, Ph.D., Head of Marketing at Alpha Vision. “By combining AI Inspector, Magic Search, and Virtual Guard, we’re empowering businesses to prevent incidents before they happen, find critical video evidence in seconds, and respond to threats proactively. These capabilities translate to real-world ROI – greater safety, lower losses, and improved efficiency across retail, property management, and more.”

Alpha Vision’s suite delivers tangible results for early adopters. Clients have reported up to a 60% reduction in parking lot incidents thanks to proactive deterrence and patrols, and approximately $80,000 in annual savings by preventing fraudulent liability claims with better incident documentation. Marketing teams have leveraged insights from the system to achieve a 30% decrease in marketing expenses, while property owners saw enhanced security drive a 25% increase in property values. These outcomes underscore the multi-faceted value of AI-powered surveillance beyond traditional security.

Key features of Alpha Vision’s AI solution suite include:

• AI Inspector – Autonomous Patrols: Automatically tours sites with a pan-tilt-zoom camera (up to 25× zoom), providing 360° coverage every few minutes. The AI engine detects trespassing, accidents or unusual behavior in real time and logs detailed reports, eliminating the need for manual guard patrols.

• Magic Search – Instant Video Search: An AI-driven video search tool that lets users find specific events or objects in recorded footage just by typing simple descriptions. It cuts video review time from hours to seconds by pinpointing exactly when and where an incident occurred, complete with map locations and snapshots.

• Virtual Guard – Live Monitoring & Alerts: A virtual security guard service that watches cameras around the clock and responds immediately to threats. It issues automatic, customizable voice warnings through speakers to intruders and sends instant alerts via text or email to security personnel, effectively stopping incidents before they escalate.

With this comprehensive suite, Alpha Vision provides an end-to-end surveillance platform adaptable to various environments. Retailers can reduce shrinkage and improve shopper safety, warehouses and factories can automate their perimeter security, and property managers can offer tenants peace of mind with around-the-clock AI protection. The integrated system works with existing security cameras, making it a cost-effective upgrade for organizations aiming to modernize their security operations.

Alpha Vision invites attendees of ISC West 2025 to visit booth #5076 for live demonstrations of AI Inspector, Magic Search, and Virtual Guard in action. Company representatives will be on hand to discuss how the technology can be tailored to different security challenges and to share success stories from recent deployments.

About Alpha Vision

Alpha Vision is a Silicon Valley-based provider of AI-powered video surveillance solutions. Founded in 2024 and headquartered in Sunnyvale, California, the company’s mission is to transform safety and operations through intelligent automation. Alpha Vision’s Agentic AI platform turns passive cameras into proactive security agents, leveraging advanced computer vision and cloud analytics to detect threats, automate responses, and deliver actionable insights. Serving clients across retail, commercial real estate, logistics, and public safety, Alpha Vision’s solutions drive smarter security decisions and measurable business results. For more information, visit alphavision.ai.

Media Contact
Company Name: Alpha Vision
Contact Person: Yi Jin, Ph.D.
Email:Send Email
Phone: 650.529.6508
Address:440 N Wolfe Rd
City: Sunnyvale
State: California
Country: United States
Website: https://www.alphavision.ai

PCSK9 Inhibitors Market Poised for Significant Growth by 2034, Predicts DelveInsight

PCSK9 Inhibitors

The PCSK9 Inhibitors market is steadily advancing, driven by evolving treatment strategies and ongoing research. DelveInsight's latest 7MM report offers in-depth insights into key epidemiology trends and market dynamics.

DelveInsight’s “PCSK9 Inhibitors - Market Insight, Epidemiology, And Market Forecast - 2034″ report offers an in-depth understanding of the PCSK9 Inhibitors, historical and forecasted epidemiology as well as the PCSK9 Inhibitors market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.

 

Some of the key facts of the PCSK9 Inhibitors Market Report:

• The PCSK9 Inhibitors Market in the 7MM was valued at approximately USD 2 billion in 2023, with the United States leading the market at around USD 900 million.

• In 2023, approximately 640K diagnosed cases of Familial Hypercholesterolemia were reported across the 7MM, with homozygous cases being extremely rare.

• Peripheral Artery Disease accounted for the highest number of risk factor-specific cases for PCSK9 inhibitors in prophylactic settings within the 7MM.

• Currently, two FDA-approved monoclonal antibodies inhibit PCSK9: PRALUENT (alirocumab) and REPATHA (evolocumab).

• Recently, the European Union and FDA approved LEQVIO (Inclisiran), a small interfering mRNA therapy that blocks intracellular PCSK9 synthesis.

• In December 2024, LIB Therapeutics submitted a Biologics License Application (BLA) to the FDA for Lerodalcibep, seeking approval to lower LDL-C in patients with ASCVD, high ASCVD risk, and primary hyperlipidemia, including HeFH and HoFH.

• Emerging therapies in the PCSK9 Inhibitors pipeline include MK-0616, LIB003 (Lerodalcibep), and others.

• Leading companies in the PCSK9 Inhibitors market include Sanofi, Regeneron Pharmaceuticals, Amgen, Novartis, Alnylam Pharmaceuticals, LIB Therapeutics, AstraZeneca, Ionis Pharmaceuticals, CiVi Biopharma, and others.

 

To know in detail about the PCSK9 Inhibitors market outlook, drug uptake, treatment scenario, and epidemiology trends, click here: PCSK9 Inhibitors Market Forecast

 

PCSK9 Inhibitors Overview

The Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) enzyme plays a crucial role in cholesterol metabolism by controlling the degradation of low-density lipoprotein (LDL) receptors, thereby affecting the clearance of circulating LDL particles. PCSK9 activity is inversely linked to LDL cholesterol (LDL-C) levels—gain-of-function mutations in the PCSK9 gene contribute to elevated LDL-C and increased cardiovascular risk in familial hypercholesterolemia (FH), while loss-of-function mutations result in lower LDL-C levels and a reduced risk of atherosclerotic cardiovascular disease (ASCVD).

 

Get a Free sample for the PCSK9 Inhibitors Market Report: https://www.delveinsight.com/report-store/pcsk9-inhibitors-psck9i-market

 

PCSK9 Inhibitors Epidemiology

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2020 to 2034. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

 

PCSK9 Inhibitors Epidemiology Segmentation

The PCSK9 Inhibitors epidemiology chapter in the report provides historical as well as forecasted epidemiology segmented by:

• Total Prevalent Cases of Familial Hypercholesterolemia in the 7MM

• Total Diagnosed Prevalent Cases of Familial Hypercholesterolemia in the 7MM

• Type-specific Diagnosed Prevalent Cases of Familial Hypercholesterolemia in the 7MM

• Age-specific Diagnosed Prevalent Cases of Familial Hypercholesterolemia in the 7MM

• Mutation-specific Diagnosed Prevalent Cases of Familial Hypercholesterolemia in the 7MM

• Risk factor-specific Cases of PCSK9 inhibitors in Prophylactic/Preventive setting in the 7MM

• Total Treated Cases of PCSK9 inhibitors in the 7MM

 

Download the report to understand which factors are driving PCSK9 Inhibitors epidemiology trends @ PCSK9 Inhibitors Epidemiology Forecast

 

PCSK9 Inhibitor Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the PCSK9 Inhibitors market or expected to be launched during the study period. The analysis covers the PCSK9 inhibitors' market uptake by drugs, patient uptake by therapies, and sales of each drug.

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the PCSK9 Inhibitors Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

 

PCSK9 Inhibitors Market Strengths

• PCSK9 inhibitors have demonstrated significant effectiveness in reducing LDL cholesterol levels, making them a preferred treatment option for patients with familial hypercholesterolemia (FH) and those at high cardiovascular risk. Their ability to lower LDL-C beyond traditional statins enhances their clinical utility.

• With increasing regulatory approvals and expanding indications, including for primary hyperlipidemia and atherosclerotic cardiovascular disease (ASCVD), PCSK9 inhibitors are gaining traction in both preventive and therapeutic settings, driving market growth.

 

PCSK9 Inhibitors Market Weaknesses

• The high price of PCSK9 inhibitors poses a significant barrier to widespread adoption, limiting access for many patients, particularly in regions with cost-sensitive healthcare systems or inadequate insurance coverage.

• Unlike oral lipid-lowering therapies, PCSK9 inhibitors require subcutaneous administration, which can affect patient adherence and preference, potentially hindering long-term treatment compliance and market penetration.

 

Scope of the PCSK9 Inhibitors Market Report

• Study Period: 2020–2034

• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]

• Key PCSK9 Inhibitors drugs: MK-0616, LIB003 (Lerodalcibep), and others.

• Key PCSK9 Inhibitors Companies: Sanofi, Regeneron Pharmaceuticals, Amgen, Novartis, Alnylam Pharmaceuticals, LIB Therapeutics, AstraZeneca, Ionis Pharmaceuticals, CiVi Biopharma, and others.

• PCSK9 Inhibitors Therapeutic Assessment: PCSK9 Inhibitors currently marketed, and PCSK9 Inhibitors emerging therapies

• PCSK9 Inhibitors Market Dynamics: PCSK9 Inhibitors market drivers and PCSK9 Inhibitors market barriers

• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies

• PCSK9 Inhibitors Unmet Needs, KOL’s views, Analyst’s views, PCSK9 Inhibitors Market Access and Reimbursement

 

To learn more about the key players and advancements in the PCSK9 Inhibitors Treatment Landscape, visit the PCSK9 Inhibitors Market Analysis Report

 

Table of Contents

1. PCSK9 Inhibitors Market Report Introduction

2. Executive Summary for PCSK9 Inhibitors

3. SWOT analysis of PCSK9 Inhibitors

4. PCSK9 Inhibitors Patient Share (%) Overview at a Glance

5. PCSK9 Inhibitors Market Overview at a Glance

6. PCSK9 Inhibitors Disease Background and Overview

7. PCSK9 Inhibitors Epidemiology and Patient Population

8. Country-Specific Patient Population of PCSK9 Inhibitors

9. PCSK9 Inhibitors Current Treatment and Medical Practices

10. PCSK9 Inhibitors Unmet Needs

11. PCSK9 Inhibitors Emerging Therapies

12. PCSK9 Inhibitors Market Outlook

13. Country-Wise PCSK9 Inhibitors Market Analysis (2020–2034)

14. PCSK9 Inhibitors Market Access and Reimbursement of Therapies

15. PCSK9 Inhibitors Market Drivers

16. PCSK9 Inhibitors Market Barriers

17. PCSK9 Inhibitors Appendix

18. PCSK9 Inhibitors Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

 

About DelveInsight DelveInsight is a leading Healthcare Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.

Media Contact
Company Name: DelveInsight
Contact Person: Jatin Vimal
Email:Send Email
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/

Cancer Monoclonal Antibodies Market Poised for Strong Growth, Projected to Expand at a 10% CAGR by 2030 - DelveInsight | GSK, F. Hoffmann-La Roche, Merck, Novartis, Johnson and Johnson Services

Cancer Monoclonal Antibodies Market

Companies like AbbVie Inc., AstraZeneca, CStone Pharmaceuticals, and HiFiBiO Therapeutics are advancing cancer monoclonal antibodies and improving diagnosis and patient outcomes.

DelveInsight’s “Cancer Monoclonal Antibodies Market Insights, Competitive Landscape, and Market Forecast–2030” report provides a comprehensive analysis of the global cancer monoclonal antibodies market, focusing on adoption trends, technological advancements, and market dynamics across key regions. The report examines market growth, offering historical and projected market sizes, revenue trends, and key factors driving the demand for monoclonal antibodies in cancer treatment.

The report highlights the evolving landscape of monoclonal antibody therapies, exploring advancements in bispecific antibodies, antibody-drug conjugates (ADCs), and immune checkpoint inhibitors that revolutionize oncology treatment. It delves into how these innovations enhance tumor targeting, improve immune system activation, and provide more effective, personalized treatment options for various cancer types.

The report also evaluates the competitive landscape, profiling major players in the global cancer monoclonal antibodies market while spotlighting emerging technologies and novel therapeutic approaches expected to drive future growth. It provides an in-depth review of ongoing clinical developments, regulatory progress, and recent product approvals, making it a vital resource for understanding the rapidly advancing field of monoclonal antibodies in cancer therapy.

 

To know in detail about the Cancer Monoclonal Antibodies market outlook, drug uptake, treatment scenario, and epidemiology trends, click here: Cancer Monoclonal Antibodies Market Forecast Report

 

Some of the key insights of the Cancer Monoclonal Antibodies Market Report:

• The cancer monoclonal antibodies market was valued at USD 80.59 billion in 2023 and is projected to grow at a CAGR of 10% from 2024 to 2030, reaching approximately USD 156.59 billion by 2030.

• According to GLOBOCAN, the global diabetic population is expected to reach 643 million by 2030 and 785 million by 2045, driving market growth during the forecast period.

• North America is estimated to hold a significant revenue share in the Cancer Monoclonal Antibodies market.

• In March 2025, BeiGene announced FDA approval of TEVIMBRA® (tislelizumab-jsgr) with platinum-based chemotherapy for first-line treatment of PD-L1 (≥1) positive unresectable or metastatic esophageal squamous cell carcinoma (ESCC). The company also plans to rebrand as BeOne Medicines Ltd.

• In January 2025, Roche announced FDA approval for a label expansion of the PATHWAY® anti-HER2/neu (4B5) assay to identify HR-positive, HER2-ultralow metastatic breast cancer patients eligible for ENHERTU®.

• In January 2025, Amgen announced FDA approval of LUMAKRAS® (sotorasib) with Vectibix® (panitumumab) for KRAS G12C-mutated metastatic colorectal cancer (mCRC) in patients previously treated with fluoropyrimidine-, oxaliplatin-, and irinotecan-based chemotherapy.

• In August 2024, AstraZeneca’s Imfinzi (durvalumab) plus chemotherapy received FDA approval for resectable early-stage (IIA-IIIB) NSCLC in patients without EGFR or ALK mutations.

• Key players in the global Cancer Monoclonal Antibodies market include GSK plc, F. Hoffmann-La Roche Ltd., Merck & Co., Inc., Novartis AG, Johnson and Johnson Services Inc., Spectrum Pharmaceuticals Inc., Eurofins Scientific, Genmab AS, Bristol Myers Squibb Company, Eli Lilly and Company, Amgen, Inc., AbbVie Inc., AstraZeneca Plc., CStone Pharmaceuticals, HiFiBiO Therapeutics, and others.

 

Cancer Monoclonal Antibodies Overview

Monoclonal antibodies have revolutionized cancer treatment by providing targeted and highly effective therapies. These laboratory-engineered molecules are designed to recognize and bind to specific antigens on cancer cells, triggering immune responses that help eliminate malignant cells. As a result, monoclonal antibody drugs have become a cornerstone of modern oncology, offering improved survival rates and better patient outcomes.

Monoclonal antibodies drugs work through multiple mechanisms, including blocking growth signals, delivering cytotoxic agents, and enhancing the body's immune response against tumors. Several FDA-approved monoclonal antibody therapies, such as trastuzumab, rituximab, and pembrolizumab, are widely used for various cancers, including breast cancer, lymphoma, and melanoma.

With continuous advancements in biotechnology, the development of next-generation monoclonal antibody drugs—such as bispecific antibodies and antibody-drug conjugates—is expanding the therapeutic landscape. As research progresses, these targeted therapies will continue to play a pivotal role in personalized cancer treatment, reducing side effects and improving patient care.

 

Get a Free sample for the Cancer Monoclonal Antibodies Market Forecast, Size & Share Analysis Report: https://www.delveinsight.com/report-store/cancer-monoclonal-antibodies-market

 

Cancer Monoclonal Antibodies Market Segment Analysis:

The Cancer Monoclonal Antibodies market report offers market segment analysis for the forecast period 2024-2030, segmented into:

• Cancer Monoclonal Antibodies Market by Type (Humanized Antibodies, Chimeric Antibodies, Murine Antibodies)

• Cancer Monoclonal Antibodies Market Application (Blood Cancer, Breast Cancer, Liver Cancer, Colorectal Cancer, and Others)

• Cancer Monoclonal Antibodies Market End-User (Hospitals, Research Institutions & Laboratories, and Others)

• Cancer Monoclonal Antibodies Market Geography (North America, Europe, Asia-Pacific, and Rest of the World)

 

Download the Cancer Monoclonal Antibodies Market Analysis report for key market trends, innovations, and growth drivers.

 

Cancer Monoclonal Antibodies Market Dynamics

The growing prevalence of cancer worldwide is a major factor driving the demand for cancer monoclonal antibodies. With an increasing number of cancer cases each year, particularly in lung, breast, colorectal, and other malignancies, the need for effective and targeted therapies continues to rise. As a result, monoclonal antibodies have emerged as a crucial treatment option, offering precision in targeting cancer cells while minimizing damage to healthy tissues.

The rising cancer burden has also fueled advancements in diagnostics, drug discovery, and research initiatives aimed at improving treatment outcomes. The expansion of clinical trials and the development of innovative monoclonal antibody therapies are expected to further accelerate market growth. Additionally, the increasing prevalence of chronic conditions like diabetes, which can contribute to cancer risk, underscores the need for continued innovation in targeted cancer treatments.

Despite the promising outlook, challenges such as stringent regulatory approvals and the extensive time required for clinical trials may pose obstacles to market expansion. However, ongoing research and the growing emphasis on personalized medicine are expected to support the continued evolution of cancer monoclonal antibody therapies in the years to come.

 

North America Set to Lead the Growth of the Global Cancer Monoclonal Antibodies Market

North America is poised to lead the Cancer Monoclonal Antibodies Market, driven by the rising incidence of cancer, increased exposure to carcinogens, and supportive regulatory approvals. Factors such as smoking, radiation exposure, and viral infections contribute to the growing cancer burden, fueling the demand for advanced treatment options.

Regulatory advancements have further strengthened market growth, with recent approvals of monoclonal antibody therapies enhancing treatment accessibility. The increasing adoption of these therapies, coupled with a high patient population, is expected to sustain North America's dominance in the market throughout the forecast period.

 

Cancer Monoclonal Antibodies Market Drivers

• The increasing global burden of cancer has driven the demand for targeted therapies like monoclonal antibodies, which offer precise treatment with fewer side effects compared to traditional chemotherapy. The growing adoption of immunotherapy in oncology is further fueling market expansion.

• Continuous innovations in monoclonal antibody technology, including bispecific antibodies and antibody-drug conjugates, enhance treatment efficacy and expand monoclonal antibody drugs' therapeutic potential across various cancer types.

 

Cancer Monoclonal Antibodies Market Barriers

• The research, development, and production of monoclonal antibody drugs are highly expensive, making these treatments costly for patients and healthcare systems, potentially limiting widespread accessibility.

• Stringent regulatory requirements and the lengthy approval process for new cancer monoclonal antibody therapies can delay market entry and hinder the rapid adoption of innovative treatments.

 

To learn more about Cancer Monoclonal Antibodies drivers and barriers, visit @ Cancer Monoclonal Antibodies Competitive Landscape and Market Forecast Report

 

Table of Contents

1. Cancer Monoclonal Antibodies Market Report Introduction

2. Cancer Monoclonal Antibodies Market Executive Summary

3. Competitive Landscape

4. Regulatory Analysis

5. Cancer Monoclonal Antibodies Market Key Factors Analysis

6. Cancer Monoclonal Antibodies Market Porter’s Five Forces Analysis

7. Cancer Monoclonal Antibodies Market Layout

8. Cancer Monoclonal Antibodies Market Company and Product Profiles

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us

 

About DelveInsight

DelveInsight is a premier healthcare business consultant and market research firm, specializing in life sciences. We empower pharmaceutical companies with comprehensive end-to-end solutions designed to enhance performance and drive growth.

Our expert healthcare consulting services offer in-depth market analysis, helping businesses accelerate growth and navigate challenges with actionable, results-driven strategies.

Media Contact
Company Name: DelveInsight
Contact Person: Jatin Vimal
Email:Send Email
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/

Acetonitrile Market Size, Share, Trends, Competitive Landscape, Regional Analysis Forecasts By 2028 | Expert Review and Top 10 Key Players Analysis

Browse 283 market data Tables and 51 Figures spread through 233 Pages and in-depth TOC on "Acetonitrile Market"

The Acetonitrile market is growing due to rising demand in pharmaceuticals, analytical applications, and agrochemicals. Innovations in production and sustainability efforts are shaping market trends. Asia-Pacific leads in consumption, with Europe and North America also seeing steady growth.

The acetonitrile market is projected to grow from USD 439 million in 2023 to USD 595 million by 2028 at a CAGR of 6.2% during the forecast period. The acetonitrile market has experienced significant expansion in recent years, driven by key factors such as rising demand, expanding customer base, and technological advancements. This report provides an in-depth analysis of the acetonitrile market size, trends, drivers, restraints, competitive landscape, and future growth opportunities.

Acetonitrile is used in a variety of applications in the analytical industry, pharmaceutical, agrochemical, and many other end-use industries, which is fuelling the market to grow across the world. The pharmaceutical industry is a major consumer of acetonitrile due to various applications such as drug synthesis, compound manufacturing, and other analytical applications. The growth of various end-use industries is having a positive impact on the global acetonitrile market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=23744345

The Derivative type segment is expected to account for the second-largest market share during the forecasted period.

Based on the type, the acetonitrile market has been segmented into solvent and derivative types. The derivative type segment accounted for the second largest market share in terms of value in 2022. It is the fastest-growing segment, owing to the increasing usage of acetonitrile as a derivative in the pharmaceutical industry. Derivative acetonitrile serves as an intermediate during the production of active pharmaceutical ingredients (APIs) and other related compounds. It also gets widely used in the synthesis of a variety of agrochemicals, including insecticides, herbicides, and fungicides.

The organic synthesis application segment is expected to account for the second-largest share of the acetonitrile market during the forecast period in terms of value.

Acetonitrile is used in pesticides, along with other compounds for the extraction of fatty acids and vegetable oils or pesticide residue. The organic synthesis segment is projected to grow at a significant CAGR during the forecast period. The growth in the organic synthesis segment is due to acetonitrile being used as raw material starting materials for various chemicals such as acetophenone thiamine, acetamidine etc.

The analytical end-use industry segment is expected to account for the second-largest share of the acetonitrile market during the forecast period in terms of value.

The analytical industry is the second-largest consumer of acetonitrile. Acetonitrile has wide usage in the analytical industry in various lab applications such as HPLC and others. Acetonitrile in the analytical industry is widely used for mobile phases in reversed-phase chromatography. Continuous research & development, along with ongoing innovations, have driven the acetonitrile market in the analytical industry across the world.

Get a Sample Copy of This Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=23744345

North America is expected to account for the third-largest share in 2022.

The acetonitrile market has been studied in Asia Pacific, North America, Europe, the Middle East & Africa, and Latin America. North America is one of the significant markets in the global acetonitrile market. Investments in R&D for drug discovery are one of the major factors driving the growth of the North American acetonitrile market. Other significant factors influencing the growth of this market in North America include the well-established pharmaceutical industry in the region, a large number of ongoing drug discovery activities, the presence of CROs, and inclination towards outsourcing of preclinical, clinical, and laboratory testing services by pharmaceutical and biopharmaceutical companies.

Acetonitrile Companies

Major manufacturers in this market are based in Asia Pacific, Europe, and North America. INEOS AG (Switzerland.), Asahi Kasei Corporation (Japan), Nova Molecular Technologies (US), PetroChina Co. Ltd. (China), Formosa Plastic Corporation (Taiwan), ShengHong Petrochemical Group Co., Ltd. (China), Avantor Performance Materials LLC (US), Imperial Chemical Corporation (Taiwan), Tedia Company Inc. (US), Avantor Performance Materials, LLC (US), Shanghai Secco Petrochemical Company Limited (China), Qingdao Shida Chemical Co., Ltd. (China), Nantong Acetic Acid Chemical Co., Ltd. (China), and others are among a few leading players operating in the acetonitrile market. Acetonitrile manufacturers have been adopting various inorganic and organic growth strategies aiming to expand and strengthen their position in the global acetonitrile market. Some of the strategies include contracts, collaborations, product launches, acquisitions, partnerships, and mergers.

INEOS AG (Switzerland)

Founded in 1998 and headquartered in Rolle, Switzerland, INEOS AG is one of the largest manufacturers of acetonitrile in the world. INEOS AG offers acetonitrile through its subsidiary INEOS Nitriles. The company offers a wide range of products for business, such as petrochemicals, specialty chemicals, oil & gas, and automotive. In the nitrile product category, the company offers acetonitrile and acrylonitrile, along with other co-products that are produced by ammonia and propylene feedstock. The company comprises 36 businesses with 194 production sites located in 29 countries across the world.

Inquire Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=23744345

Asahi Kasei Corporation (Japan)

Asahi Kasei Corporation is one the leading Japanese companies providing products and solutions for various industries such as fibers & textiles, chemicals, electronics, homes, and healthcare. The company offers its products through three segments that include materials, homes, and health care. Through its material segment, the company offers three grades of acetonitrile, namely, chemical grade, reagent grade, and highly purified grade, under its acetonitrile product segment. The company was founded in 1931 and is headquartered in Tokyo, Japan. The company has a strong supply chain network and a wide geographic presence across the world.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America’s best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies – helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email:Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/acetonitrile-market-23744345.html

UV-Curable Resins Market Trends (2024-2029): Global Size, Key Segments, and Top 10 Key Players Analysis with Expert Review

Browse 397 market data Tables and 73 Figures spread through 307 Pages and in-depth TOC on "UV-Curable Resins Market"

UV-curable resins companies are driving innovation in coatings, adhesives, and 3D printing with fast-curing, eco-friendly solutions. As demand for sustainable and high-performance materials grows, these companies continue to expand their market presence, offering enhanced durability, efficiency, and environmental benefits.

The UV-curable resins market is projected to grow from USD 6.48 billion in 2024 to USD 9.31 billion by 2029, at a CAGR of 7.5% during the forecast period. The UV-curable resins market has experienced significant expansion in recent years, driven by key factors such as rising demand, expanding customer base, and technological advancements. This report provides an in-depth analysis of the UV-curable resins market size, trends, drivers, restraints, competitive landscape, and future growth opportunities.

The demand for UV-curable resins is driven by growing investments, rising advancement in technologies, growing applications, and increasing focus on sustainability. UV-curable resins have been increasingly adopted in various end-use industries due to growing focus on minimizing volatile organic compounds emission. UV-curable resins provide eco-friendly alternative to other traditional thermal curing methods that enables manufacturers to get align with global sustainable goals. Stricter environmental laws about emissions are promoting the usage of UV-curable resins across the world.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1324

Additives segment is expected to grow with highest CAGR in UV-curable resins market during the forecasted period.

The UV-curable resins market is segmented based on the composition into oligomers, monomers, photoinitiators, and additives. Additives are being highly incorporated aiming to improve the overall curing process, flexibility, resistance to environmental factors and adhesive properties. The growing demand for eco-friendly and sustainable solutions that helps to minimize the environmental impact is driving the growth of the market across the world. Additives also helps to cater the specific needs of various end-use industries. It also helps to enhance adhesin and scratch resistance in graphic arts and packaging sectors.

Waterborne UV resins segment is expected to grow with highest CAGR in UV-curable resins market during the forecasted period.

The UV-curable resins market is segmented based on technology. In recent years, the use of waterborne UV resins has surged in many end-use industries. Industries such as building & construction, automotive, electrical & electronics, and packaging are shifting towards to usage of waterborne UV resins for various applications. Recent developments in European Union regarding environmental and health legislations have been expanding the adoption of waterborne UV resins. In most of the cases, these formulations possess up to 80% of water with very small amount of other solvents like glycol ethers.

Paper & packaging industry segment is expected to have largest share during forecasting period in terms of value.

Paper & packaging industry dominated the market in terms of value. UV-curable resins are getting widely utilized for various applications including coatings, printing inks, adhesives and sealants. The rise I e-commerce has been driving significant demand for options in packaging solutions. UV-curable coatings and inks helps to enhance the durability and visual appeal of the packaging materials attracting consumers in such as competitive market.

Get a Sample Copy of This Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=1324

Asia Pacific region dominated the global UV-curable resins market in terms of value

In 2023, Asia Pacific accounted for the largest share in the global UV-curable resins market, in terms of value. The region includes emerging and high growing markets like India and China that contributes to the growth of overall market. It also has presence of many leading market players such as Resonac Holdings Corporation (Japan), Wanhua Chemical Group Co., Ltd. (China), DIC Corporation (Japan), Dexerials Corporation (Japan), Eternal Materials Co., Ltd. (Taiwan), and Toagosei Co., Ltd. (Japan). Strong growth for UV-curable resins from paper & packaging industry is expected to drive he market significantly during forecasted years.

UV Curable Resins Companies

The major players active in the UV-curable resins market are based in Europe, Asia Pacific, and North America region. Allnex Netherlands B.V. (Germany), BASF SE (Germany), Alberdingk Boley GmbH (Germany), Covestro AG (Germany), Wanhua Chemical Group Co., Ltd. (China), Miwon Specialty Chemical Co., Ltd. (South Korea), IGM Resins (Netherlands), DIC Corporation (Japan), Arkema (France), Resonac Holdings Corporation (Japan), Threebond International, Inc. (US), Toagosei Co., Ltd. (Japan), Rternal Materials Co., Ltd. (Taiwan), Dexerials Corporation (Japan), and Nissan Chemical Corporation (Japan) are among a few leading players operating in the UV-curable resins market.

Many of the key players have been implementing various growth strategies to solidify their market presence and position. These strategies encompass product launches, partnerships, contracts, mergers and acquisitions, and new product development activities, all aimed at enhancing their presence in the UV-curable resins market.

Alberdingk Boley GmbH (Germany)

Alberdingk Boley GmbH is one of the largest European producers of water-based dispersions, biobased dispersions, castor oil, linseed oil, and its derivatives for paints & coatings, adhesives, varnishes, building protection, and printing inks. It offers water-based polymer dispersions, water-based polyurethane dispersions, water-based acrylate dispersions, solvent-free polyurethane dispersions, solvent-free polyurethane/ acrylate hybrid dispersions, water-based polyurethane & acrylate dispersions, water-based UV-curable dispersions, VOC-free polyols & hydroxyl functional acrylates, and derivatives. Other than Europe, the company has its production and development center spread across North America and Asia region.

Inquire Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=1324

Covestro AG (Germany)

Covestro AG, the parent company of Covestro Group, is one of the leading global suppliers of high-tech polymer materials and application solutions. The company operates its business under two reportable segments: namely Performance Materials and Solutions & Specialties. It offers wide range of high-performance materials such as polyurethane and polycarbonates under a wide range of high-performance materials such as polyurethane and polycarbonates under the performance materials segment. The solutions & specialties segment is further divided into six business entities which include engineering plastics, coatings & adhesives, tailored urethanes, thermoplastic polyurethanes, specialty films, which include engineering plastics, coatings & adhesives, tailored urethanes, thermoplastic polyurethanes, specialty films, and elastomers. Covestro AG has 48 production sites and 13 R&D sites in Europe, the Middle East, Africa, Latin America, North America, and Asia Pacific regions.

Wanhua Chemical Group Co., Ltd. (China)

Wanhua Chemical Group Co., Ltd. is one of the leading manufacturers and suppliers of innovative chemical products. The company operates under various business units. It offers a diverse range of products under four segments: polyurethane, performance chemicals, petrochemicals, and emerging materials. It also provides high-quality and efficient industry solutions for electronics, sports and leisure, construction, transportation, medical care, resources and energy, paints & coatings, adhesives, and 3D printing. The company has well-established R&D centers and production facilities in China. Its sales and distribution network are spread across various regions.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America’s best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies – helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email:Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/uv-curable-resins-market-1324.html

Biopharmaceutical Process Analytical Technology Market Worth $2.6 billion | MarketsandMarkets™

Thermo Fisher Scientific Inc. is introducing innovative solutions to address analytical challenges in diverse laboratory settings. With the launch of the Thermo Scientific Dionex Inuvion lori Chromatography (IC) system, the company aims to simplify and enhance ion analysis processes

key players operating in the global biopharmaceutical process analytical technology market are Thermo Fisher Scientific, Inc. (US), Danaher Corporation (US)

Biopharmaceutical Process Analytical Technology Market in terms of revenue was estimated to be worth $1.2 billion in 2024 and is poised to reach $2.6 billion by 2029, growing at a CAGR of 16.0% from 2024 to 2029 according to a new report by MarketsandMarkets™.

The global embrace of Process Analytical Technologies (PAT) is propelled by heightened research investment from biopharmaceutical firms, rigorous regulatory criteria for drug safety, improvements in drug quality, and technological advancements.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=95920337

Liquid chrpmatography/HPLC segment to register significant growth rate over the forecast period of 2024-2029.

Based on the type, the global biopharmaceutical process analytical market has been classified into segments— liquid chromatography/HPLC, Gas chromatography, mass spectrometry, real-time PCR/QPCR, NGS, NMR spectroscopy, raman spectroscopy, infrared spectroscopy, particle counters and imaging, differential light scattering, and other techniques. Liquid chromatography/HPLC segment is anticipated to register significant growth. The wide-ranging use of chromatography within the biopharmaceutical sector, spanning tasks such as quantifying pharmaceutical compounds, identifying pathogens, measuring proteins, and supporting biochemistry and biophysics investigations, emphasizes its significance. Moreover, stringent regulatory standards governing drug development and safety play a significant role in driving its global growth.

Analyzers segment accounted for the largest share of the biopharmaceutical process analytical technology, by product type market in 2023.

Based on product type, Analyzers segment dominates the biopharmaceutical process analytical technology market, and the trend is expected to continue over the forecast period. In 2023, This sector claimed the largest share due to advancements in process analytical techniques, which provide operational efficiency and decrease process cycle times.

Online analysis segment dominated the market in terms of measurement, in 2023.

Based on mode, In 2023, the dominant segment in the biopharmaceutical process analytical technology tools market was online analysis. The swift processing and dependable outcomes were credited to the efficient monitoring of crucial process parameters (CPP) throughout drug development and manufacturing. A range of analytical methods, such as on-line, in-line, at-line, and off-line approaches, were utilized to effectively analyze CPP.

North America market to hold major share in the market during the forecast period.

Based on region, North America, comprising the US and Canada, accounted for the largest share of the global biopharmaceutical process analytical technology market in 2023. The primary factors fueling this market encompass the availability of research funding, stringent regulations overseeing drug development, and the increasing prevalence of conferences, discussions, symposiums, and seminars centered around analytical technologies.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=95920337

Biopharmaceutical Process Analytical Technology Market Dynamics:

Drivers:

1. Increasing demand for enhancing the quality of manufacturing processes

Restraints:

1. High cost of PAT deployment

Opportunities:

1. Healthcare costs are on the rise in developing nations

Challenge:

1. Lack of skilled professionals

Key Market Players of Biopharmaceutical Process Analytical Technology Industry:

As of 2023, prominent players in the biopharmaceutical process analytical technology market are Waters Corporation (US), Thermo Fisher Scientific, Inc. (US), Danaher Corporation (US), Agilent Technologies, Inc. (US), Shimadzu Corporation (Japan), Bruker Corporation (US), Emerson Electric Co. (US), ABB Ltd. (Switzerland), PerkinElmer, Inc. (US), Mettler-Toledo International Inc. (US), and Carl Zeiss AG (Germany), among others.

A breakdown of the primary participants referred to for this report is provided below:

• By Company Type: Tier 1 30%, Tier 2–42%, and Tier 3– 28%
• By Designation: C-level–14%, D Level–10%, and Others–76%
• By Region: North America–40%, Europe–30%, Asia Pacific–22%, Latin America–6%, and the Middle East & Africa–2%

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=95920337

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email:Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/biopharmaceutical-process-analytical-technology-market-95920337.html

The US Vitamin Gummies Market to Hit $3.47 Billion by 2029 | Growing at a CAGR of 6.94% - Arizton

U.S. Vitamin Gummies Market Research Report by Arizton

   

According to Arizton’s latest research report, the US vitamin gummies market is growing at a CAGR of 6.94% during 2023-2029.

      

To Know More, Click: https://www.focusreports.store/report/us-vitamin-gummies-market

     

Report Summary       

Market Size (2029): $3.47 Billion   

Market Size (2023): $2.32 Billion  

CAGR (2023-2029): 6.94%  

Historic Year: 2020-2022  

Base Year: 2023  

Forecast Year: 2024-2029  

Market Segmentation: Source, Gender, End-User, Application, and Distribution Channel

      

The U.S. vitamin gummies market has seen significant growth, with more consumers favoring gummy vitamins over traditional pill forms. This expansion is largely driven by increased health awareness and the rising popularity of convenient supplement options. The market is also experiencing a surge of innovation as companies work to meet changing consumer preferences and stand out in a competitive landscape. Vendors are introducing novel and exotic flavors to enhance the appeal of gummy vitamins. For example, in March 2024, the supplement brand Nature Made released a limited-edition pickle-flavored version of its multivitamin gummies, inspired by the growing popularity of pickles and pickleball. Additionally, companies are creating gummy vitamins that offer multiple benefits in a single product, such as blends of multivitamins designed to support immunity, energy, and overall wellness. There is a growing consumer demand for personalized nutrition solutions that cater to individual health needs and genetic profiles. Brands are also innovating with new formulations that incorporate additional nutrients and address specific health concerns, such as immune support, sleep aids, and beauty benefits. The trend towards natural and organic ingredients continues to rise, with many brands emphasizing non-GMO, gluten-free, and vegan options.

 

Key Development

• In February 2024, Nature Made, a leading national brand in vitamins and supplements, announced the expansion of its multivitamin portfolio. It introduced the Nature Made Advanced Multivitamin Gummies, a new line of easily consumable gummies designed to address common dietary deficiencies.
• In 2023, SmartyPants Vitamins launched a revamped version of its gummy products line, formulated without gelatin. These new products, including kids, teenagers, and Women’s multivitamin gummies with fresh flavors, made their debut in Walmart stores nationwide.

 

 

E-Commerce Segment Growth in Vitamin Gummies Market

The e-commerce segment demonstrates remarkable growth as a distribution channel, boasting the fastest-growing compound annual growth rate (CAGR) during the forecast period. This expansion is largely driven by the ease of access to a wide range of brands and products, as well as the availability of customer reviews and ratings that assist consumers in making informed purchasing decisions.

The landscape of distribution channels for vitamin gummies in the U.S. has evolved significantly, with online retail platforms and Direct-to-Consumer (D2C) strategies becoming increasingly important. These channels have been instrumental in the growth and widespread adoption of vitamin gummies, addressing the rising demand for convenient and enjoyable nutritional supplements.

Major online retail platforms such as Amazon, Walmart, and Target play a crucial role in this sector. They offer extensive reach and convenience, enabling consumers to buy vitamin gummies from the comfort of their homes. The robust logistics networks and prime membership benefits provided by these platforms, including expedited and often same-day delivery, significantly enhance customer satisfaction and drive the growth of the e-commerce segment.

 

Buy this Research @ https://www.focusreports.store/report/us-vitamin-gummies-market

 

Key Vendors

• Amway
• Bayer
• Church & Dwight
• Dr. Willmar Schwabe
• Haleon
• Nestle
• Pharmavite
• Procter & Gamble
• Reckitt Benckiser Group
• Unilever
• Amazon
• NATURELO
• GNC Holdings
• Kirkland Signature
• Nature's Craft
• Nordic Naturals
• Shaklee
• Hero Nutritionals
• Vytalogy Wellness
• Walmart
• Country Life
• Dollar General
• Enzymedica
• Hi-Health
• Doctor's Best
• NATURAL ORGANICS
• Nature's Sunshine Products
• Orphic Nutrition
• SugarbearPRO
• Vegums
• Walgreens
• Herbaland
• Zanon

 

Segmentation & Forecast

Source

• Plant-based
• Animal-based

Gender

• Male
• Female

End-User

• Pediatric
• Adult

Application

• General & Immune Health
• Energy & Weight Management
• Bone & Joint Health
• Others

Distribution Channel

• Pharmacies & Drugstores
• Supermarket & Hypermarkets
• E-Commerce
• Specialty Stores
• Others

 

Key Questions Answered in the Report:      

How big is the U.S. vitamin gummies market?

What are the key drivers of the U.S. vitamin gummies market?

What is the growth rate of the U.S. vitamin gummies market?

Who are the major players in the U.S. vitamin gummies market?

     

Why Arizton?                                     

100% Customer Satisfaction                                     

24x7 availability – we are always there when you need us                                     

200+ Fortune 500 Companies trust Arizton's report                                     

80% of our reports are exclusive and first in the industry                                     

100% more data and analysis                                     

1500+ reports published till date                   

      

Post-Purchase Benefit                                 

1hr of free analyst discussion                                 

10% off on customization              

      

About Us:                                                                          

Arizton Advisory and Intelligence is an innovative and quality-driven firm that offers cutting-edge research solutions to clients worldwide. We excel in providing comprehensive market intelligence reports and advisory and consulting services. 

We offer comprehensive market research reports on consumer goods & retail technology, automotive and mobility, smart tech, healthcare, life sciences, industrial machinery, chemicals, materials, I.T. and media, logistics, and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts.

Arizton comprises a team of exuberant and well-experienced analysts who have mastered generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.

Media Contact
Company Name: Arizton Advisory & Intelligence
Contact Person: Jessica
Email:Send Email
Phone: +1 3122332770
Country: United States
Website: https://www.focusreports.store/report/us-vitamin-gummies-market

Stange Law Firm Relocates Lincoln, Nebraska Office in Lancaster County

LINCOLN, Ne. - March 31, 2025 - Stange Law Firm is excited to announce that the firm’s Lincoln, Nebraska family law office is relocating to a larger office space to continue to provide clients with compassionate and dedicated legal representation. Starting on April 1, 2025, the new office for the Lincoln, Nebraska divorce lawyers will be located at 770 N. Cotner Blvd, Suite 302, Lincoln, Nebraska 68505. The new office is just five miles from the firm’s previous office.

Stange Law Firm has had a presence in Lincoln, NE since 2022. At just over 1,300 sq. ft, the new office location will allow for the Lincoln family law attorneys to continue to effectively represent individuals throughout Lancaster County, and nearby, in matters including divorce, child custody or child support, spousal support, adoption, paternity, and estate planning.

Lincoln serves as the capital city of the state of Nebraska. Collectively, the Lincoln, Nebraska metropolitan area is home to over 345,000 people. Founded in 1856 as Lancaster and re-named after President Abraham Lincoln in 1869, the city serves as the second-most populous city in Nebraska and the 71st most populous in the United States.

Stange Law Firm was founded in St. Louis, MO in 2007 and has since grown to become the second-largest divorce and family law firm in the United States. Currently, the firm operates 27 offices throughout Missouri, Illinois, Kansas, Oklahoma, Nebraska, Indiana, Iowa, Kentucky, and Texas. In Nebraska, Stange Law Firm also operates a full-time office in Douglas County in Omaha. The firm strives to provide clients with caring and diligent legal representation throughout the duration of their family law case. The team at Stange Law Firm understands that these cases can be strenuous on individuals. As a result, clients are offered 24/7 access to their file online as well as the personal cell phone number of their assigned attorney should an issue arise outside of normal business hours.

No matter the family law issue, Stange Law Firm is here to help you rebuild your life. To schedule a consultation or learn more about the firm’s new Lincoln, Nebraska family law office, call 855-805-0595 or visit www.stangelawfirm.com.

Media Contact
Company Name: Stange Law Firm
Contact Person: Kevin Fowler
Email:Send Email
Phone: 855-805-0595
Address:770 N. Cotner Blvd, Suite 302
City: Lincoln
State: Nebraska, 68505
Country: United States
Website: https://www.stangelawfirm.com/

New novel "Dirty 4" by Keenan A. Bailey is released, a visceral exploration of grief, substance abuse, and the struggle for stability in a chaotic world

“Dirty 4” by Keenan A. Bailey has been released worldwide. This 184-page novel follows Kelvin Blake from ages 18 to 26 as he navigates a complex world of mental health challenges, grief, substance abuse, and strained relationships, striving to find peace and balance among the noise of his thoughts. Written in the first person, this descriptive work of literary fiction brings readers into the tumultuous inner thoughts of the protagonist to build a raw, relatable view of life’s many difficulties.

Bridging the painful, the comical, and the philosophical, Bailey brings Kelvin to life through interior monologue, reflecting the anxieties that so many people face but rarely express out loud. As an exploration of trauma, self-sabotage, and resulting cynicism, Kelvin provides a cathartic window into the turmoil of young adulthood.

As readers accompany Kelvin through highs and lows, the author uses his relationships and experiences to offer social commentary, from sex and poverty to art, pop culture, and athletics. Kelvin is firmly placed in the real world, and the dynamics of modern society are as much a part of the story as his internal struggles.

Organized in four “Quarters” (including Halftime) to reflect Kelvin’s love of playing football, and spanning his experiences with others, his relentless self-criticism, and his creative attempts to process his pain, the book remains compelling and imaginative throughout.

A psychological thriller at its core, this vivid depiction of a young man in crisis tackles the dysfunction and coping mechanisms that lead young men down dark paths of drugs, alcohol, and desperate attempts to feel whole.

Dirty 4 (ISBN: 9781966074038) can be purchased through retailers worldwide, including Amazon and Barnes & Noble. The paperback retails for $14.85, and the ebook retails for $2.99. Review copies and interviews with the author are available upon request.

From the back cover:

A darkly funny psychological thriller, Dirty 4 is a gripping exploration into tribulation.

Dirty 4 is written in first person and delves into the philosophical in some areas, the comical in others, and the full-on painful as Kelvin uses narration, dialogue, and internal thought to relay his story to the reader – In a voice that is raw and honest, Kelvin spares no detail in telling the compelling, heartbreaking story of his journey.

About the author:

Based in upstate New York, Keenan A. Bailey is a psychotherapist who developed a passion for writing later in his life. He is a bestselling author on Amazon. During his free time he mostly enjoys being around his son, reading Yelp reviews about various establishments, and enjoying the outdoors. Bailey’s writing is solely based on experience, emotion, and imagination. Dirty 4 is his debut book.

About Manhattan Book Group:

Manhattan Book Group (“MBG”), located on Broadway in New York City, is a registered trade name of Mindstir Media LLC. MBG is widely known as a premier hybrid book publisher. We have combined the best of traditional publishing with the best of self- publishing to provide authors with the “best of both worlds” in a sense. 

To learn more about MBG, visit https://www.manhattanbookgroup.com/

Media Contact
Company Name: Manhattan Book Group
Contact Person: Jen McNabney
Email:Send Email
Phone: 212-634-7677
Address:447 Broadway 2nd Floor #354
City: New York
State: New York
Country: United States
Website: https://www.manhattanbookgroup.com/

Revolutionary AI feature for Bicycle Dealers

Mar 31, 2025 - BikeFolder, the Norwegian bicycle software company, is now launching IBA (Intelligent Booking Assistant) for all its users. This AI-based feature, developed over the past eight months, helps bike retailers worldwide digitize the most crucial aspect of their operations. Using advanced algorithms and artificial intelligence, IBA is specifically designed for bike workshops, focusing on increasing margins, streamlining daily operations, and optimizing incoming repair jobs.

Automated Monitoring and Calculation

IBA keeps track of how busy the workshop is and figures out the best time for repairs and maintenance. The system helps bike shops anticipate needs and maximize capacity while ensuring a seamless experience for customers.

30% Increased Efficiency

The technology has been tested for 8 months on more than 100 dealers, and user feedback shows a significant improvement in efficiency. Workshops using IBA have, on average, repaired 30% more bikes compared to previous performance.

Huge Potential for Bike Retailers

Data shows that only 15-20% of all bikes needing annual service actually receive maintenance. Modern bikes are highly technical and expensive, and owners of bikes valued between $1,000–$10,000 USD are eager to have their bikes serviced regularly. IBA helps bike shops identify these service needs and actively attract more customers. An average bike shop with five years of operation typically has over 5,000 customers and bikes linked to the shop. This results in approximately 750 annual repairs, but the potential is much greater. With IBA, the shop can automatically send SMS reminders to customers based on available workshop capacity, creating opportunities to service the remaining 4,250 bikes. IBA organizes and verifies data by creating a digital bike garage for customers, where all bikes purchased or repaired in the shop are stored with their own “bike card.” Artificial intelligence ensures high data quality, forming the foundation for automated functions that enhance shop operations.

Completely Free for Bike Shops

BikeFolder’s booking system is 100% free for bike shops. The system includes in-store booking, an online booking link, and IBA. It works globally, and setup takes only 10 minutes.

"BikeFolder aims to address the challenges of low digitization and data quality in the bike industry. The primary objective is to simplify the daily operations of bike shops with the use of smart, automated solutions like IBA." - Sondre Norland, CEO and Founder of BikeFolder

About BikeFolder

BikeFolder is a leading software company in the bike industry. Its three specialized software solutions optimize and streamline operations for bike manufacturers, bike shops, and bike owners worldwide.

For more information, visit www.bikefolder.com

IBA calculator: https://bikefolder.com/en/kalkulator/

General press enquiries: press@bikefolder.com

CEO and Founder: Sondre Norland. sondre@bikefolder.com

Media Contact
Company Name: BikeFolder
Email:Send Email
Country: Norway
Website: www.bikefolder.com